Biotech

All Articles

A deeper look at Ferocious Biotech's Brutal 15

.Within this week's incident of "The Best Line," our company're diving in to Fierce Biotech's yearly...

Lilly experiences stage 2 failing of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's gathering commemorating the commenda...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, firings as...

Lykos are going to talk to FDA to rethink its choice following denial of MDMA treatment for post-traumatic stress disorder

.Adhering to a poor presenting for Lykos Therapies' MDMA applicant for trauma at a recent FDA consul...

AN 2 one-halfs roll call, stops phase 3 test after information let down

.AN2 Therapeutics is actually reassessing its own company in feedback to lackluster midphase records...

Merck spends $700M for bispecific, spying autoimmune opening as well as possibility to challenge Amgen in cancer

.Merck &amp Co. is paying out $700 thousand beforehand to challenge Amgen in a blood stream cancer m...

Gilead pays out J&ampJ $320M to exit licensing offer for seladelpar

.With Gilead Sciences almost an FDA decision for its liver ailment medication seladelpar, the busine...

' All hands on deck' at Lilly as peers target obesity market

.CEO David Ricks may observe the business putting together camping tents at basecamp behind Eli Lill...

Entero giving up staff, vacating workplace as well as pausing R&ampD

.Cushion Liquidators has actually switched Entero Therapies white colored as a piece. The lender ord...

Exelixis drops ADC after deciding it is actually no suit for Tivdak

.Exelixis is actually quiting on its own cells aspect (TF)- targeting antibody-drug conjugate after ...